Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors

被引：14
|
作者：
Lv, Yongcong [1 ]
Li, Mengyuan [2 ,3 ]
Liu, Ting [1 ,4 ]
Tong, Linjiang [2 ]
Peng, Ting [2 ]
Wei, Lixin [3 ]
Ding, Jian [2 ]
Xie, Hua [2 ]
Duan, Wenhu [1 ]
机构：
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Med Chem, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China
[3] Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai 81008, Peoples R China
[4] Nanchang Univ, Coll Med, Nanchang 330066, Jiangxi, Peoples R China
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2014年 / 5卷 / 05期
基金：
中国国家自然科学基金;
关键词：
Angiogenesis; HUVEC; inhibitor; naphthamide; VEGFR-2; ENDOTHELIAL GROWTH-FACTOR; RENAL-CELL CARCINOMA; FACTOR RECEPTOR; CANCER; ANGIOGENESIS; DISEASE;
D O I：
10.1021/ml5000417
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Inhibition of VEGFR-2 signaling pathway has already become one of the most promising approaches for the treatment of cancer. In this study, we describe the design, synthesis, and biological evaluation of a new series of naphthamides as potent inhibitors of VEGFR-2. Among these compounds, 14c exhibited high VEGFR-2 inhibitory potency in both enzymatic and HUVEC cellular proliferation assays, with IC50 values of 1.5 and 0.9 nM, respectively. Kinase selectivity profiling revealed that 14c was a multitargeted inhibitor, and it also exhibited good potency against VEGFR-1, PDGFR-beta, and RET. Furthermore, 14c effectively blocked tube formation of HUVEC at nanomolar level. Overall, 14c might be a promising candidate for the treatment of cancer.
引用
收藏
页码：592 / 597
页数：6
相关论文
共 50 条
  • [31] Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
    Shi, Leilei
    Zhou, Jianfeng
    Wu, Jifeng
    Shen, Yuemao
    Li, Xun
    [J]. CURRENT MEDICINAL CHEMISTRY, 2016, 23 (10) : 1000 - 1040
  • [32] Discovery of New Quinazoline-Based Anticancer Agents as VEGFR-2 Inhibitors and Apoptosis Inducers
    M. F. Ahmed
    A. S. Khalifa
    E. M Eed
    [J]. Russian Journal of Bioorganic Chemistry, 2022, 48 : 739 - 748
  • [33] Discovery of New Quinazoline-Based Anticancer Agents as VEGFR-2 Inhibitors and Apoptosis Inducers
    Ahmed, M. F.
    Khalifa, A. S.
    Eed, E. M.
    [J]. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2022, 48 (04) : 739 - 748
  • [34] Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors.
    Kuo, GH
    Wang, AH
    Emanuel, S
    DeAngelis, A
    Zhang, R
    Connolly, PJ
    Murray, WV
    Gruninger, RH
    Sechler, J
    Fuentes-Pesquera, A
    Johnson, D
    Middleton, SA
    Jolliffe, L
    Chen, X
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U950 - U950
  • [35] Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity
    Munchhof, MJ
    Beebe, JS
    Casavant, JM
    Cooper, BA
    Doty, JL
    Higdon, RC
    Hillerman, SM
    Soderstrom, CI
    Knauth, EA
    Marx, MA
    Rossi, AMK
    Sobolov, SB
    Sun, JM
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 21 - 24
  • [36] Discovery of a novel series of potent sphingosine kinase 1 and 2 dual inhibitors
    Li, Yihong
    Brown, Matthew
    Schmitt, Mike
    Wang, Sheldon
    Wanska, Maggie
    Connors, Richard
    Kayser, Frank
    Min, Xiaoshan
    Johnstone, Sheree
    Romanow, Bill
    Wang, Zhulun
    Cardozo, Mario
    Walker, Nigel
    Frank, Brendon
    Li, Shyun
    Wesche, Holger
    Shen, Shanling
    Wong, Mariwil
    Jeffries, Shawn
    Plant, Matthew
    Morgenstern, Kurt
    Xu, Guifen
    Carlson, Timothy
    Rex, Karen
    Gustin, Darin
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [37] Design, synthesis, and antitumor screening of new thiazole, thiazolopyrimidine, and thiazolotriazine derivatives as potent inhibitors of VEGFR-2
    Abd Elhameed, Alaa A.
    Ali, Ahmed R.
    Ghabbour, Hazem A.
    Bayomi, Said M.
    El-Gohary, Nadia S.
    [J]. DRUG DEVELOPMENT RESEARCH, 2023, 84 (08) : 1664 - 1698
  • [38] Quinoxalinone (Part II). Discovery of (Z)-3-(2-(pyridin-4-yl)vinyl)quinoxalinone derivates as potent VEGFR-2 kinase inhibitors
    Shi, Leilei
    Zhou, Jianfeng
    Wu, Jifeng
    Cao, Junya
    Shen, Yuemao
    Zhou, Hua
    Li, Xun
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (08) : 1840 - 1852
  • [39] Discovery of New Quinazoline Derivatives as VEGFR-2 Inhibitors: Design, Synthesis, and Anti-proliferative Studies
    Dhawale, Sachin A.
    Dabhade, Pratap S.
    Mokale, Santosh N.
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (18) : 2042 - 2055
  • [40] Impact of aryloxy-linked quinazolines: A novel series of selective VEGFR-2 receptor tyrosine kinase inhibitors
    Garofalo, Antonio
    Goossens, Laurence
    Six, Perrine
    Lemoine, Amelie
    Ravez, Severine
    Farce, Amaury
    Depreux, Patrick
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (07) : 2106 - 2112
12345